AUROBINDO PHARMA LTD. - Outcome of Board Meeting

	< Back
06 Nov 2015
Aurobindo Pharma Ltd has informed BSE that the Board of Directors of the Company at its meeting held on November 06, 2015, inter alia, accorded revised approval for raising funds through issue of Equity / GDRs / ADRs / FCCBs or any other equity related instruments upto an amount of USD 600 million or rupee equivalent thereof subject to approval of the shareholders of the Company and other necessary approvals. The Board has also decided to seek approval of the shareholders through postal ballot for the above purpose.
View all announcements for AUROBINDO PHARMA LTD.	Source: BSE India

Stocks	Mutual Funds		Investment tracking
A-Z Gainers - Daily \| Weekly \| Monthly Losers - Daily \| Weekly \| Monthly Group-wise listing IPO \| Top IPOs Recent IPOs \| IPO News Similar Price band Most traded - By volumes Top 100 - By market capitalisation Latest Company Results Management Speaks Market News	Top 25 schemes High-risk, High-returns Medium-risk, Medium-returns Low-risk, Low-returns Gilt Funds Funds of Funds Special Funds Liquid Funds Dynamic Asset Allocation NFOs MF Selector	Equity - ELSS Equity - Index Funds Equity - Sector Funds Equity - Balance Fund Equity - Diversified Fund MF News Budget 2024	My Portfolio My Watch List If You Had Invested... Global Indicators Forex Converter Market Indices Sectoral Indices World Indices Market Astrology Advertise with us